Blood Cancer Journal (Sep 2022)
High response rates with single-agent belantamab mafodotin in relapsed systemic AL amyloidosis
- Jahanzaib Khwaja,
- Joshua Bomsztyk,
- Shameem Mahmood,
- Brendan Wisniowski,
- Raakhee Shah,
- Anish Tailor,
- Kwee Yong,
- Rakesh Popat,
- Neil Rabin,
- Charalampia Kyriakou,
- Jonathan Sive,
- Simona Degli Esposti,
- Daniel F. P. Larkin,
- Sarah Worthington,
- Alyse Hart,
- Emma Dowling,
- Nuno Correia,
- Ceri Bygrave,
- Andrzej Rydzewski,
- Krzysztof Jamroziak,
- Ashutosh D. Wechalekar
Affiliations
- Jahanzaib Khwaja
- Department of Haematology, University College London Hospital
- Joshua Bomsztyk
- National Amyloidosis Centre, University College London (Royal Free Campus)
- Shameem Mahmood
- National Amyloidosis Centre, University College London (Royal Free Campus)
- Brendan Wisniowski
- National Amyloidosis Centre, University College London (Royal Free Campus)
- Raakhee Shah
- Department of Haematology, University College London Hospital
- Anish Tailor
- Department of Haematology, University College London Hospital
- Kwee Yong
- Department of Haematology, University College London Hospital
- Rakesh Popat
- Department of Haematology, University College London Hospital
- Neil Rabin
- Department of Haematology, University College London Hospital
- Charalampia Kyriakou
- Department of Haematology, University College London Hospital
- Jonathan Sive
- Department of Haematology, University College London Hospital
- Simona Degli Esposti
- Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology
- Daniel F. P. Larkin
- Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology
- Sarah Worthington
- Department of Haematology, University College London Hospital
- Alyse Hart
- Department of Haematology, University College London Hospital
- Emma Dowling
- Department of Haematology, University College London Hospital
- Nuno Correia
- Department of Haematology, University College London Hospital
- Ceri Bygrave
- Department of Haematology, University Hospital of Wales
- Andrzej Rydzewski
- Department of Internal Medicine, Nephrology and Transplantation Medicine, Central Clinical Hospital of the Ministry of Internal Affairs
- Krzysztof Jamroziak
- Department of Hematology, Transplantation and Internal Medicine, Medical University of Warsaw
- Ashutosh D. Wechalekar
- National Amyloidosis Centre, University College London (Royal Free Campus)
- DOI
- https://doi.org/10.1038/s41408-022-00717-2
- Journal volume & issue
-
Vol. 12,
no. 9
pp. 1 – 3
Abstract
No abstracts available.
